大洋生物：股东拟减持不超57万股公司股份

Group 1 - The core point of the article is that Dayang Bio (003017) announced on December 17 that shareholder Wang Xiangao plans to reduce his holdings in the company by a total of no more than 570,000 shares, which accounts for up to 0.68% of the company's total shares [1]